- Home
- WDAY vs BSX Comparison
WDAY vs BSX Comparison
Compare WDAY & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WDAY
- BSX
- Stock Information
- Founded
- WDAY 2005
- BSX 1979
- Country
- WDAY United States
- BSX United States
- Employees
- WDAY N/A
- BSX N/A
- Industry
- WDAY EDP Services
- BSX Medical/Dental Instruments
- Sector
- WDAY Technology
- BSX Health Care
- Exchange
- WDAY Nasdaq
- BSX Nasdaq
- Market Cap
- WDAY 62.7B
- BSX 146.2B
- IPO Year
- WDAY 2012
- BSX 1992
- Fundamental
- Price
- WDAY $224.52
- BSX $98.84
- Analyst Decision
- WDAY Buy
- BSX Strong Buy
- Analyst Count
- WDAY 29
- BSX 19
- Target Price
- WDAY $285.76
- BSX $124.53
- AVG Volume (30 Days)
- WDAY 1.9M
- BSX 8.0M
- Earning Date
- WDAY 11-25-2025
- BSX 10-22-2025
- Dividend Yield
- WDAY N/A
- BSX N/A
- EPS Growth
- WDAY N/A
- BSX 54.68
- EPS
- WDAY 2.16
- BSX 1.87
- Revenue
- WDAY $8,959,000,000.00
- BSX $19,349,000,000.00
- Revenue This Year
- WDAY $14.95
- BSX $21.04
- Revenue Next Year
- WDAY $12.63
- BSX $11.45
- P/E Ratio
- WDAY $103.88
- BSX $52.97
- Revenue Growth
- WDAY 13.94
- BSX 21.61
- 52 Week Low
- WDAY $205.33
- BSX $85.03
- 52 Week High
- WDAY $294.00
- BSX $109.50
- Technical
- Relative Strength Index (RSI)
- WDAY 38.69
- BSX 46.54
- Support Level
- WDAY $228.05
- BSX $98.06
- Resistance Level
- WDAY $241.32
- BSX $102.27
- Average True Range (ATR)
- WDAY 6.46
- BSX 1.83
- MACD
- WDAY -1.42
- BSX -0.14
- Stochastic Oscillator
- WDAY 14.15
- BSX 17.29
About WDAY Workday Inc.
Workday is a software company that offers human capital management, financial management, and business planning solutions for enterprises. Known for being a cloud-only software provider, Workday was founded in 2005 and is headquartered in Pleasanton, California.
About BSX Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.